Navigation Links
Patch Form of HRT Poses Less Clotting Risks Than Pill Does
Date:5/22/2008

Analysis finds pill more than doubles risk while patch only increases it slightly

THURSDAY, May 22 (HealthDay News) -- Women who take hormone replacement therapy via skin patches may face a lower risk of blood clots than women who take the therapy orally.

The new finding could change the risk-benefit ratio for women who are considering hormone therapy to relieve hot flashes, night sweats and other symptoms of menopause.

"One main clinical implication is to consider transdermal rather than oral estrogen for women at high cardiovascular risk in order to avoid thrombosis [blood clots], which is the main harmful effect of short-term hormone therapy," said Dr. Pierre-Yves Scarabin, director of research at the National Institute of Health and Medical Research in France, and senior author of a study published in the May 23 online issue of the British Medical Journal.

Previous studies have found an increased risk not only of blood clots, but also coronary heart disease and breast cancer among postmenopausal women who take hormone replacement therapy (HRT).

But, according to background information in the paper, no one has assessed how high the increased risk is, or whether the risk varies with the type of therapy.

Scarabin and his colleagues reviewed data from eight observational studies and nine randomized controlled trials on HRT and venous thromboembolism (VTE), a potentially fatal blood clot in the vein.

Pool results indicated that the risk of VTE was 2.5 times higher in women taking oral estrogen compared to women taking no estrogen. The risk was most pronounced during the first year of treatment and in women who were overweight or predisposed toward developing blood clots.

By contrast, women currently using the patch had only a slightly elevated risk compared to women taking no estrogen.

Women who had stopped taking HRT saw their risk return to normal.

According to the authors, the increased risk translates into an additional 1.5 events per 1,000 women per year.

Most of the data came from existing observational trials, however, not the gold-standard randomized trials, so the findings should be interpreted with caution, the authors warned.

Other experts agreed.

"It's observational and very interesting, but clearly more studies need to be done," said Dr. Suzanne Steinbaum, director of women and heart disease at Lenox Hill Hospital in New York City. "Maybe this opens the door for a way to give hormones more safely to those who need it."

More information

Visit the National Heart, Lung, and Blood Institute for more on hormone replacement therapy.



SOURCES: Pierre-Yves Scarabin, M.D., director, research, National Institute of Health and Medical Research, and cardiovascular epidemiology section, Paul Brousse Hospital, Villejuif, France; Suzanne Steinbaum, D.O., director, women and heart disease, Lenox Hill Hospital, New York City; May 23, 2008, British Medical Journal


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. The First QPatch HT in China Placed in WuXi PharmaTech (NYSE: WX)
2. Iomai Wins Department of Defense Grant to Develop a Stable, Patch-Based Anthrax Vaccine
3. Study Finds Single Dose of Iomai Patch With Pandemic Flu Vaccine Achieves Protective Levels
4. Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th
5. PriCara(TM) Recalls 25 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches
6. Iomai Study Shows Self-Applied Travelers Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch
7. Ringing endorsement: Women prefer contraceptive ring over patch
8. FDA Warns Clot Risk Higher in Birth Control Patch Than Pill
9. FDA Renews Warnings on Pain-Relief Patch
10. Studies of 20,000 smokers show quit rates double with counseling and free nicotine patches
11. ActiPatch(TM) Granted Market Clearance by the Food & Drug Administration in the Kingdom of Jordan
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Patch Form of HRT Poses Less Clotting Risks Than Pill Does 
(Date:1/17/2017)... ... January 17, 2017 , ... Gym Source, America’s leading retailer of ... at South Dixie Hwy in Miami, FL. , “We are elated to be opening ... innovative in-store concept is designed to give clients a seamless and motivating shopping experience.” ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... SunView Software’s ... Award for Innovation of the Year. , Each year, Pink Elephant recognizes ... an innovative approach to address a specific business problem or opportunity. The award highlights ...
(Date:1/17/2017)... , ... January 17, 2017 , ... Mirror Mirror Beauty ... the highest honor of Diamond Level in Zeltiq’s Crystal Rewards Program. Practice founder, Paul ... of this elite group of providers. , Produced by Zeltiq, CoolSculpting is approved ...
(Date:1/17/2017)... Houston, TEXAS (PRWEB) , ... January 17, 2017 ... ... solution provider, today announced its partnership with Sigfox in the U.S.A. ... to cities nationwide including new offerings on large-scale environmental sensor deployments such ...
(Date:1/17/2017)... ... 2017 , ... Seceon , the only threat detection ... announced a strategic partnership with TechLab Security, a leading Enterprise Systems ... Security has become a strategic partner and a value added reseller of Seceon’s ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... -- Secretary of Health Dr. Karen Murphy ... are warning Pennsylvanians of the potentially lethal risks ... the drug in Beaver County . ... animals and is not meant for humans – it ... it," Secretary Murphy said. "It,s absolutely essential that first ...
(Date:1/17/2017)... 2017 Research and Markets has announced ... - 2024" report to their offering. ... This new report revisits the market ... was issued in May of 2015. Self-healing is an area of ... analysis we projected a market potential of $2.7 billion ($US) by ...
(Date:1/17/2017)... -- The Global Nebulizers Market is poised to grow ... decade to reach approximately $1698.68 million by 2025. Some ... include rapidly growing demand in emerging regions, increasing use ... and online marketing strategies by key players. ... pneumatic nebulizers, ultrasonic nebulizers and mesh nebulizers. Pneumatic nebulizers ...
Breaking Medicine Technology: